SciVision Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	886.62	883.31	712.99	557.35	505.54
Revenue Growth (YoY)	0.38%	23.89%	27.93%	10.25%	8.28%
Cost of Revenue	248.23	227.63	200.49	185.48	163.7
Gross Profit	638.39	655.68	512.49	371.87	341.84
Selling, General & Admin	355.28	346.86	259.44	184.8	153.95
Research & Development	93.19	60.71	53.42	52.46	65.94
Operating Expenses	448.47	407.57	312.86	237.26	219.89
Operating Income	189.92	248.11	199.64	134.61	121.94
Interest Expense	-7.93	-5.67	-8.22	-6.46	-8.07
Interest & Investment Income	24.42	20.61	14.9	4.88	2.63
Currency Exchange Gain (Loss)	-	20.48	-0.51	11.81	-1.46
Other Non Operating Income (Expenses)	-21.37	1.43	0.75	0.17	1.01
EBT Excluding Unusual Items	185.04	284.96	206.56	145.02	116.05
Gain (Loss) on Sale of Investments	-	6.45	2.9	-1.98	-0.13
Gain (Loss) on Sale of Assets	-	0.19	0.54	30.55	0.13
Other Unusual Items	-	-	-	-0.04	-
Pretax Income	185.04	291.6	210	173.55	116.06
Income Tax Expense	22.7	49.34	32.1	31.83	14.34
Net Income	162.34	242.25	177.9	141.72	101.72
Net Income to Common	162.34	242.25	177.9	141.72	101.72
Net Income Growth	-32.99%	36.17%	25.53%	39.32%	-20.53%
Shares Outstanding (Basic)	72	69	67	66	66
Shares Outstanding (Diluted)	74	74	76	75	71
Shares Change (YoY)	-0.00%	-2.58%	2.39%	5.18%	0.61%
EPS (Basic)	2.24	3.51	2.66	2.14	1.54
EPS (Diluted)	2.18	3.30	2.41	1.92	1.51
EPS Growth	-33.98%	37.15%	25.26%	27.30%	-20.11%
Free Cash Flow	22.46	235.11	257.28	167.03	72.73
Free Cash Flow Per Share	0.30	3.16	3.37	2.24	1.02
Dividend Per Share	-	3.250	2.500	2.000	1.420
Dividend Growth	-	30.00%	25.00%	40.84%	60.49%
Gross Margin	72.00%	74.23%	71.88%	66.72%	67.62%
Operating Margin	21.42%	28.09%	28.00%	24.15%	24.12%
Profit Margin	18.31%	27.43%	24.95%	25.43%	20.12%
Free Cash Flow Margin	2.53%	26.62%	36.08%	29.97%	14.39%
EBITDA	270.35	310.17	261.42	195.35	173.08
EBITDA Margin	30.49%	35.12%	36.66%	35.05%	34.24%
D&A For EBITDA	80.43	62.06	61.78	60.74	51.14
EBIT	189.92	248.11	199.64	134.61	121.94
EBIT Margin	21.42%	28.09%	28.00%	24.15%	24.12%
Effective Tax Rate	12.27%	16.92%	15.29%	18.34%	12.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.